<?xml version='1.0'?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:georss="http://www.georss.org/georss" xmlns:atom="http://www.w3.org/2005/Atom" >
<channel>
	<title><![CDATA[BOL: Related items]]></title>
	<link>https://bioinformaticsonline.com/related/41604?offset=210</link>
	<atom:link href="https://bioinformaticsonline.com/related/41604?offset=210" rel="self" type="application/rss+xml" />
	<description><![CDATA[]]></description>
	
	<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/blog/view/45358/the-variant-everyone-ignored</guid>
	<pubDate>Mon, 05 Oct 2026 12:14:20 -0500</pubDate>
	<link>https://bioinformaticsonline.com/blog/view/45358/the-variant-everyone-ignored</link>
	<title><![CDATA[The Variant Everyone Ignored]]></title>
	<description><![CDATA[<p>Consider a scenario in which a patient's genome has been sequenced. Among billions of DNA bases, a structural alteration may explain the patient's disease. Multiple advanced algorithms analyze the data, yet only one detects the variant, while the others do not. In standard bioinformatics workflows, such a solitary result is often regarded as unreliable and subsequently discarded. Although the solution exists within the data, prevailing computational protocols may overlook it.</p><p>A recent study published in Genome Biology (https://link.springer.com/article/10.1186/s13059-026-04280-y) addressed this challenge by introducing dicast (https://github.com/burgshrimps/dicast), a machine-learning approach for detecting structural variants in short-read sequencing data. Structural variants, such as large deletions, insertions, duplications, and inversions, can have significant biological and clinical implications, yet they are challenging to identify with short-read technologies. Because different detection methods frequently yield divergent results, researchers commonly employ consensus calling, considering a variant valid only if multiple tools detect it. While this approach reduces false positives, it relies on the potentially flawed assumption that the majority is always correct.</p><p>The researchers explored the impact of evaluating the supporting evidence for each variant, rather than simply tallying the number of algorithms that identified it. To establish a ground truth, they analyzed nine genomes using multiple sequencing technologies and 15 detection methods, initially identifying approximately 35 million potential variants. Through extensive filtering, evidence integration, and manual review of over 11,500 variants, they developed a robust benchmark comprising more than 236,000 structural variants. The findings underscored the complexity of the problem: short-read methods detected fewer than half of deletions and less than 10 percent of insertions, with performance declining markedly in repetitive genomic regions. In contrast, long-read technologies demonstrated superior detection capabilities. However, replacing the substantial volume of existing short-read data in clinical and research settings is not immediately feasible. Consequently, the researchers questioned whether short-read data might harbor more information than conventional analytical pipelines currently extract.</p><p>This line of inquiry led to the development of dicast. Rather than merely confirming agreement among multiple tools, dicast identifies patterns in sequencing data, including split and clipped reads, discordant read pairs, alignment characteristics, and the surrounding genomic context. An XGBoost machine-learning model evaluates which combinations of these signals are indicative of genuine structural variants. Thus, the approach shifts from tallying algorithmic consensus to interpreting the underlying evidence.</p><p>The researchers subsequently conducted a targeted evaluation by examining structural variants detected by only a single short-read tool, which are typically missed by consensus-based approaches. dicast successfully recovered approximately 81% of these single-caller deletions, insertions, and duplications. The signals for these variants were present in the data, but conventional filtering methods failed to integrate them effectively.</p><p>The utility of dicast was further demonstrated in cohorts with rare diseases, including congenital limb malformations, atrial fibrillation, and neuromuscular disorders. In one instance, dicast achieved a deletion recall rate of approximately 0.96, compared to 0.74 using consensus calling. The median number of variants requiring manual review was 29 per sample. Among 31 experimentally validated variants that standard filters would have missed, dicast identified 12, whereas consensus calling detected only one.</p><p>Overall, dicast identified approximately 20 percent more potential disease-causing deletions than consensus-based methods. While a 20 percent increase may appear modest, in clinical genomics such improvements can have significant practical implications. Missing a deletion may leave a case unresolved, whereas detecting a structural variant can provide critical diagnostic insights.</p><p>The study does not claim that machine learning has rendered short-read sequencing superior to long-read approaches. Instead, the results underscore the effectiveness of long-read sequencing for structural variant detection. However, dicast highlights a more nuanced perspective: substantial biological information may still be recoverable from the extensive short-read datasets already available.</p><p>The principal lesson extends beyond the detection of structural variants. For many years, bioinformatics pipelines have relied on threshold-based criteria, such as minimum coverage, quality scores, or support from multiple tools. While these rules are useful, biological phenomena do not always conform to rigid checklists; multiple weak signals, when considered collectively, can provide compelling evidence.</p><p>This perspective prompts consideration of the solitary variant: one algorithm identifies it, while several others do not. Traditional consensus techniques might have dismissed it, yet machine learning approaches evaluate the available evidence to determine whether the variant is plausible.</p><p>Occasionally, the most significant variant within a genome is the one that is almost universally overlooked.</p><p>Read more at&nbsp;https://link.springer.com/article/10.1186/s13059-026-04280-y</p>]]></description>
	<dc:creator>BioStar</dc:creator>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/researchlabs/view/861/fiona-brinkman-laboratory</guid>
  <pubDate>Sun, 14 Jul 2013 12:46:31 -0500</pubDate>
  <link></link>
  <title><![CDATA[Fiona Brinkman Laboratory]]></title>
  <description><![CDATA[
<p>Infectious disease control needs to be made more “sustainable”. We need to reduce selective pressure on pathogens to evolve antibiotic resistance. We need to control infectious disease outbreaks and associated immune disorders with a better understanding of the genetic,  environmental and social factors that impact disease spread and severity.</p>

<p>Research Area</p>

<p>Investigating the role in disease of both the microbe and its host (i.e immune system failure), using genomics and systems biology-based approaches<br />Using genomics and network analysis to characterize disease outbreaks and their environmental/social/genetic causes, and<br />Identifying new anti-infective and immune modulating therapies/biomarkers.</p>

<p>Link @ http://www.brinkman.mbb.sfu.ca/</p>
]]></description>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/pages/view/879/bioprogramming</guid>
	<pubDate>Sun, 14 Jul 2013 16:29:53 -0500</pubDate>
	<link>https://bioinformaticsonline.com/pages/view/879/bioprogramming</link>
	<title><![CDATA[BioProgramming]]></title>
	<description><![CDATA[<p>The completion of the first human genome drafts was just a start of the modern DNA sequencing era which resulted in further invention, improved development toward new advanced strategies of high-throughput DNA sequencing, so called the &ldquo;high-throughput next generation sequencing&rdquo; (HT-NGS). The decreasing genome sequencing cost and desire to explore and understand biological machanism at genomic level, speed up the genomic sequencing projects. In the fast growing HT-NGS technologies, the main challenge is to cope with the analysis of vast production of sequencing database through advanced bioinformatics tools. In oder to develope sotware/tools bioinformatician/ biological programmers need to expertise in any one one the programming language. However, sometime one language are not enough to handle all sort of biological needs, which compel us to learn new biologically suitable language to handle ever growing genome or protein sequences.</p><p>The next step after reading genetic code is writing a script to analyse and explore the hidden information. This tutorial is aimed to introduce you new biological programming languages with their packages/libraries, and assist in your scripting work.</p><p>Navigate the sub-section of this page [ see right hand side of the page for it ]</p>]]></description>
	<dc:creator>Jitendra Narayan</dc:creator>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/opportunity/view/1215/livestock-functional-genomics-summer-school-lfg-2013</guid>
  <pubDate>Fri, 02 Aug 2013 09:57:37 -0500</pubDate>
  <link></link>
  <title><![CDATA[Livestock Functional Genomics Summer School (LFG 2013)]]></title>
  <description><![CDATA[
<p>*Livestock Functional Genomics Summer School - Call for applications*</p>

<p>1st Livestock Functional Genomics Summer School (LFG 2013).</p>

<p>This School was designed for graduate students and early-stage researchers with interest in livestock genomics, who are engaged in projects that require knowledge in the field of computational biology.</p>

<p>Sixty selected participants will spend 13 days receiving theoretical and practical training in genomic data handling from internationally renowned experts.</p>

<p>After the course, the participant should understand the basis and the context of livestock big molecular data, and be able to manipulate high density genotypes, whole genome sequences and transcriptome data.</p>

<p>The Summer School will be held in Araçatuba-SP Brazil, from the 13th to the 21st of September 2013.</p>

<p>All accepted participants will have *expenses fully covered (air ticket, hotel and meals)*, including a free pass to the 5th International Symposium on Animal Functional Genomics http://www.isafg2013.org.br </p>

<p>Applicants will be selected based on their résumés. Application date is due by August 10th.  Results will be announced in August 12th.  </p>

<p>Please consult website: http://www.sciencesatellite.org.br/sschool</p>
]]></description>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/pages/view/1514/list-of-pharmacogenomics-companies-worldwide</guid>
	<pubDate>Fri, 09 Aug 2013 13:24:47 -0500</pubDate>
	<link>https://bioinformaticsonline.com/pages/view/1514/list-of-pharmacogenomics-companies-worldwide</link>
	<title><![CDATA[List of pharmacogenomics companies worldwide]]></title>
	<description><![CDATA[<div><div><p>Pharmacogenomics are the most promising area of research. Here is the list of some Pharmacogenomics companies worldwide. Feel free to add more pharmacogenomics companies if not mentioned in here.</p><p>Great Pharmacogenomics companies <br /><a href="http://www.aruplab.com/">www.aruplab.com</a> <br /><a href="http://www.clarientinc.com/">www.clarientinc.com</a> <br /><a href="http://www.cns-hts.com/">www.cns-hts.com</a> <br /><a href="http://www.dnanow.com/">www.dnanow.com</a> <br /><a href="http://www.dnavision.be/">www.dnavision.be</a> <br /><a href="http://www.dnavision.com/">www.dnavision.com</a> <br /><a href="http://www.dxsdiagnostics.com/">www.dxsdiagnostics.com</a> <br /><a href="http://www.entrogen.com/">www.entrogen.com</a> <br /><a href="http://www.exiqon.com/">www.exiqon.com</a> <br /><a href="http://www.gene.com/">www.gene.com</a> <br /><a href="http://www.genomichealth.com/">www.genomichealth.com</a> <br /><a href="http://www.genoptix.com/">www.genoptix.com</a> <br /><a href="http://www.genpathdiagnostics.com/">www.genpathdiagnostics.com</a> <br /><a href="http://www.gentris.com/">www.gentris.com</a> <br /><a href="http://www.immunicon.com/">www.immunicon.com</a> <br /><a href="http://www.ingenuity.com/">www.ingenuity.com</a> <br /><a href="http://www.lab21.com/">www.lab21.com</a> <br /><a href="http://www.labcorp.com/">www.labcorp.com</a> <br /><a href="http://www.lion-ag.de/">www.lion-ag.de</a> <br /><a href="http://www.lynxgen.com/">www.lynxgen.com</a> <br /><a href="http://www.mayoclinic.com/">www.mayoclinic.com</a> <br /><a href="http://www.mesoscale.com/">www.mesoscale.com</a> <br /><a href="http://www.microcide.com/">www.microcide.com</a> <br /><a href="http://www.mitokor.com/">www.mitokor.com </a> <br /><a href="http://www.monarchlifesciences.com/">www.monarchlifesciences.com</a> <br /><a href="http://www.mplnet.com/">www.mplnet.com</a> <br /><a href="http://www.orchidbio.com/">www.orchidbio.com</a> <br /><a href="http://www.pebio.com/">www.pebio.com</a> <br /><a href="http://www.phenomenome.com/">www.phenomenome.com</a> <br /><a href="http://www.phenopath.com/">www.phenopath.com</a> <br /><a href="http://www.ppgx.com/">www.ppgx.com</a> <br /><a href="http://www.prometheuslabs.com/">www.prometheuslabs.com</a> <br /><a href="http://www.protogene.com/">www.protogene.com</a> <br /><a href="http://www.questdiagnostics.com/">www.questdiagnostics.com</a> <br /><a href="http://www.rigelinc.com/">www.rigelinc.com</a> <br /><a href="http://www.rii.com/">www.rii.com</a> <br /><a href="http://www.saladax.com/">www.saladax.com</a> <br /><a href="http://www.tmdlab.com/">www.tmdlab.com</a> <br /><a href="http://www.transgenomic.com/">www.transgenomic.com</a> <br /><a href="http://www.twt.com/">www.twt.com</a> <br /><a href="http://www.uslabs.net/">www.uslabs.net</a> <br /><a href="http://www.variagenics.com/">www.variagenics.com</a> <br /><br />Great Equipment Companies for Genomics <br /><a href="http://www.affymetrix.com/">www.affymetrix.com</a> <br /><a href="http://www.illumina.com/">www.illumina.com</a> <br /><a href="http://www.iontorrent.com/">www.iontorrent.com</a> <br /><a href="http://www.sequenom.com/">www.sequenom.com</a> <br /><a href="http://www.appliedbiosystems.com/">www.appliedbiosystems.com</a> <br /><a href="http://www.454.com/">www.454.com</a> <br /><a href="http://www.appliedbiosystems.com/">www.appliedbiosystems.com</a><br /><br />Genomics in India <br /><a href="http://www.ganitlabs.in/">www.ganitlabs.in</a> <br /><a href="http://www.sandor.co.in/">www.sandor.co.in</a> <br /><a href="http://www.igib.res.in/">www.igib.res.in</a> <br /><a href="http://www.genotypic.co.in/">www.genotypic.co.in</a> <br /><a href="http://www.ocimumbio.com/">www.ocimumbio.com</a> <br /><a href="http://www.abcgenomics.com/">www.abcgenomics.com</a> <br /><a href="http://www.xcelrisgenomics.com/">www.xcelrisgenomics.com</a> <br /><a href="http://www.ayugen.com/">www.ayugen.com</a> <br /><a href="http://www.geneombiotech.com/">www.geneombiotech.com</a> <br /><br /> Large Global Whole Genome Companies <br /><a href="http://www.decode.com/">www.decode.com</a> <br /><a href="http://www.23andme.com/">www.23andme.com</a> <br /><a href="http://www.navigenics.com/">www.navigenics.com</a><br />www.pathway.com<br /><br /> Global companies offering genomics services <br /><a href="http://www.asuragen.com/">www.asuragen.com</a> <br /><a href="http://www.baseclear.com/">www.baseclear.com</a> <br /><a href="http://www.agtcenter.com/">www.agtcenter.com</a> <br /><a href="http://www.ambrygen.com/">www.ambrygen.com</a> <br /><a href="http://www.arosab.com/">www.arosab.com</a> <br /><a href="http://www.agrf.org.au/">www.agrf.org.au</a> <br /><a href="http://www.beckmangenomics.com/">www.beckmangenomics.com</a> <br /><a href="http://www.genomics.cn/">www.genomics.cn</a> <br /><a href="http://www.bsf.a-star.edu.sg/">www.bsf.a-star.edu.sg</a> <br /><a href="http://www.cbm.fvg.it/">www.cbm.fvg.it</a> <br /><a href="http://www.cincinnatichildrens.org/">www.cincinnatichildrens.org</a> <br /><a href="http://www.cofactorgenomics.com/">www.cofactorgenomics.com</a> <br /><a href="http://www.covance.com/">www.covance.com</a> <br /><a href="http://www.dnalandmarks.ca/">www.dnalandmarks.ca</a> <br /><a href="http://www.dnavision.com/">www.dnavision.com</a> <br /><a href="http://www.expressionanalysis.com/">www.expressionanalysis.com</a> <br /><a href="http://www.fasteris.com/">www.fasteris.com</a> <br /><a href="http://www.gatc-biotech.com/">www.gatc-biotech.com</a> <br /><a href="http://www.genesdiffusion.com/">www.genesdiffusion.com</a> <br /><a href="http://www.geneseek.com/">www.geneseek.com</a> <br /><a href="http://www.geneticvisions.com/">www.geneticvisions.com</a> <br /><a href="http://www.geneworks.com.au/">www.geneworks.com.au</a> <br /><a href="http://www.genizon.com/">www.genizon.com</a> <br /><a href="http://www.genoskan.dk/uk">www.genoskan.dk/uk</a> <br /><a href="http://www.gpbio.jp/">www.gpbio.jp</a> <br /><a href="http://www.igatechnology.com/">www.igatechnology.com</a> <br /><a href="http://www.igenixinc.com/">www.igenixinc.com</a> <br /><a href="http://www.auxologico.it/">www.auxologico.it</a> <br /><a href="http://www.lifeandbrain.com/">www.lifeandbrain.com</a> <br /><a href="http://www.macrogen.co.kr/eng">www.macrogen.co.kr/eng</a> <br /><a href="http://www.gqinnovationcenter.com/">www.gqinnovationcenter.com</a> <br /><a href="http://www.mftservices.de/">www.mftservices.de</a> <br /><a href="http://www.ncgr.org/">www.ncgr.org</a> <br /><a href="http://www.ramaciotti.unsw.edu.au/">www.ramaciotti.unsw.edu.au</a> <br /><a href="http://www.rikengenesis.jp/">www.rikengenesis.jp</a> <br /><a href="http://www.sabiosciences.com/">www.SABiosciences.com</a> <br /><a href="http://www.sequensysbio.com/">www.sequensysbio.com</a> <br /><a href="http://www.servicexs.com/">www.servicexs.com</a> <br /><a href="http://www.snp-genetics.com/">www.snp-genetics.com</a> <br /><a href="http://www.takara-bio.com/">www.takara-bio.com</a> <br /><a href="http://www.gen-probe.com/">www.gen-probe.com</a> <br /><a href="http://www.traitgenetics.com/">www.traitgenetics.com</a></p></div></div>]]></description>
	<dc:creator>Jitendra Narayan</dc:creator>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/opportunity/view/1720/postdoctoral-associate-bioinformatics-at-duke-university-medical-center</guid>
  <pubDate>Sat, 10 Aug 2013 18:38:38 -0500</pubDate>
  <link></link>
  <title><![CDATA[Postdoctoral Associate - Bioinformatics  at Duke University Medical Center]]></title>
  <description><![CDATA[
<p>The Department of Biostatistics and Bioinformatics at Duke University Medical Center is seeking a Postdoctoral Associate for a one year appointment to work on several high-dimensional research projects. The specific goals of the project are to identify genes or molecular markers that are predictive of clinical outcomes in renal and prostate cancer.</p>

<p>Candidates must have: a PhD degree in statistics, biostatistics or bioinformatics, extensive experience in analyzing high-dimensional data (microarray, SNP, CNVs) and of validation approaches. In addition, experience in penalized regression methods, data base manipulation; and strong programming skills in order to conduct Monte Carlo studies and applications (R). Candidate must have excellent communication skills (verbal, written and presentation), a strong proficiency in Linux system.</p>

<p>This position is available immediately and will be filled as soon as possible. Appointment could be extended beyond the first year based on additional funding.</p>

<p>For more information about the Department of Biostatistics and Bioinformatics, please visit our website: http://www.biostat.duke.edu.</p>

<p>For more info: http://biostat.duke.edu/sites/biostat.duke.edu/files/Halabi%20-%20Postdoc%20Job%20Posting%202013%20updated.pdf</p>

<p>Duke University is an Equal Opportunity/Affirmative Action Employer.</p>
]]></description>
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/opportunity/view/2335/embo-practical-course-bioinformatics-large-scale-data-at-shenzhen-china</guid>
  <pubDate>Wed, 14 Aug 2013 09:50:56 -0500</pubDate>
  <link></link>
  <title><![CDATA[EMBO Practical Course, Bioinformatics, large-scale data, at Shenzhen, China]]></title>
  <description><![CDATA[
<p>This international advanced course will provide training on bioinformatics and statistics methods for genomic research. It will give insight into how biological knowledge can be generated from high-throughput sequencing (DNA-Seq, RNA-seq, ChIP-seq) experiments and will illustrate how to analyze such data. The course covers both the underlying statistical and algorithmic concepts, and the practice of how to automate and code such analyses using the scripting language R.</p>

<p>17 Nov 2013 -22 Nov 2013</p>

<p>More at http://events.embo.org/13-large-scale-data/</p>

<p>Online Registration: https://www.conference-service.com/pc13-47/welcome.cgi</p>
]]></description>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/bookmarks/view/2492/plos-computational-biology-translational-bioinformatics-educational-resources</guid>
	<pubDate>Fri, 16 Aug 2013 12:24:56 -0500</pubDate>
	<link>https://bioinformaticsonline.com/bookmarks/view/2492/plos-computational-biology-translational-bioinformatics-educational-resources</link>
	<title><![CDATA[PLOS Computational Biology: Translational Bioinformatics educational resources]]></title>
	<description><![CDATA[<p>PLOS present collection of Education articles:&nbsp; &ldquo;Translational Bioinformatics&rdquo;. This collection is presented as an online &ldquo;book&rdquo; which could serve as a reference tool for a graduate level introductory course, marking a step in an exciting new direction for the Education section of the journal.</p>
<p>Blog : http://blogs.plos.org/biologue/2012/12/28/translational-bioinformatics-plos-computational-biology-presents-an-educational-resource-for-an-emerging-field/</p>
<p>Educational Material : http://www.ploscollections.org/article/browseIssue.action?issue=info:doi/10.1371/issue.pcol.v03.i11</p><p>Address of the bookmark: <a href="http://www.ploscollections.org/article/browseIssue.action?issue=info:doi/10.1371/issue.pcol.v03.i11" rel="nofollow">http://www.ploscollections.org/article/browseIssue.action?issue=info:doi/10.1371/issue.pcol.v03.i11</a></p>]]></description>
	<dc:creator>Jitendra Narayan</dc:creator>
</item>
<item>
	<guid isPermaLink="true">https://bioinformaticsonline.com/videolist/watch/3963/spotlight-on-genomics-understanding-our-genes-a-step-to-personalized-medicine</guid>
	<pubDate>Mon, 26 Aug 2013 17:07:44 -0500</pubDate>
	<link>https://bioinformaticsonline.com/videolist/watch/3963/spotlight-on-genomics-understanding-our-genes-a-step-to-personalized-medicine</link>
	<title><![CDATA[Spotlight on Genomics: Understanding Our Genes - A Step to Personalized Medicine]]></title>
	<description><![CDATA[<iframe width="" height="" src="https://www.youtube-nocookie.com/embed/GQqKRkPQXmk" frameborder="0" allowfullscreen></iframe>(Visit: http://www.uctv.tv/) Learn about the essential role of genomics in the development of stem cell based therapies. Craig Venter, president and founder of the J. Craig Venter Institute and Catriona Jamieson, director for stem cell research at the UCSD Moores Cancer Center, speak about the future of personalized medicine in which genomics, the study of genes and their function, is applied to pinpoint specific treatments for patients. Sandra Dillon, a clinical trial participant, gives a patient's perspective. [7/2013] [Health and Medicine] [Show ID: 24530]]]></description>
	
</item>

<item>
  <guid isPermaLink='true'>https://bioinformaticsonline.com/researchlabs/view/4656/pandey-lab</guid>
  <pubDate>Fri, 20 Sep 2013 13:19:18 -0500</pubDate>
  <link></link>
  <title><![CDATA[Pandey Lab]]></title>
  <description><![CDATA[
<p>The Pandey Lab at Johns Hopkins University is a Systems Biology lab that combines molecular biology, analytical chemistry and computational biology with various "Omics" technologies including genomics and proteomics to understand signaling pathways and to identify therapeutic targets and biomarkers in a number of cancers.</p>

<p>More at http://pandeylab.igm.jhmi.edu/</p>

<p>http://scholar.google.com/citations?user=OhuG0FcAAAAJ&amp;hl=en</p>
]]></description>
</item>

</channel>
</rss>